Status regarding Novo Nordisk's holding of its own shares (30 June 2017)
Bagsværd, Denmark, 3 July 2017
- In continuation of the company's announcements dated 2 February 2017 and 3 May 2017 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 30 June 2017 owned 26,782,349 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 5,356,470 or 1.1% of the total share capital.
In the second quarter of 2017 a total of 13,768,358 B shares were repurchased, and 17,871 B shares were disposed to employees in connection with employee incentive programmes.
Further information
Media: | ||
Anne Margrethe Hauge | +45 4442 3450 | amhg@novonordisk.com |
Ken Inchausti (US) | +1 609 786 8316 | kiau@novonordisk.com |
Investors : |
||
Peter Hugreffe Ankersen | +45 3075 9085 | phak@novonordisk.com |
Hanna Ögren | +45 3079 8519 | haoe@novonordisk.com |
Anders Mikkelsen | +45 3079 4461 | armk@novonordisk.com |
Kasper Veje (US) | +1 609 235 8567 | kpvj@novonordisk.com |
Company announcement No 53 / 2017
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via GlobeNewswire